B. Scatton

D. Duverger, E. Mackenzie, L. Rouquier, 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage

C. Carter, D. Fage, J. Bénavidès, 1987, Brain Research.

Difluoromethyl ornithine protects against the neurotoxic effects of intrastriatally administered N-methyl-D-aspartate in vivo.

C. Carter, D. Fage, B. Scatton, 1991, European journal of pharmacology.

Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.

Y. Claustre, B. Scatton, K. Lloyd, 1987, The Journal of pharmacology and experimental therapeutics.

Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat

C. Feuerstein, D. Fage, B. Scatton, 1984, Brain Research.

In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.

H. Schoemaker, Y. Claustre, J. Bénavidès, 1995, Arzneimittel-Forschung.

Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.

B. Scatton, K. Lloyd, D. Duval, 1995, Arzneimittel-Forschung.

New perspectives for the treatment of disorders of sleep and arousal.

D. Sanger, B. Scatton, C. Soubrane, 2007, Annales pharmaceutiques francaises.

Autoradiographic localization of dopamine receptors in the spinal cord of the rat using [3H]-N-propylnorapomorphine

B. Scatton, A. Dubois, A. Cudennec, 2005, Journal of Neural Transmission.

Lack of circadian rhythm in plasma levels of 3,4-dihydroxyphenylethyleneglycol in healthy human subjects

C. Benkelfat, H. Lôo, B. Scatton, 2004, Psychopharmacology.

Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle.

H. Lôo, B. Scatton, G. Fur, 1985, Neuropsychobiology.

EFFECT OF NEUROLEPTICS ON DOPAMINE METABOLISM IN THE RAT FRONTAL CORTEX

B. Scatton, 1980 .

High doses of haloperidol in schizophrenia. A clinical, biochemical, and pharmacokinetic study.

H. Lôo, B. Scatton, G. Bianchetti, 1982, Archives of general psychiatry.

Effects of cyclo (Leu-Gly) on neurochemical indices of striatal dopaminergic supersensitivity induced by prolonged haloperidol treatment.

D. Fage, B. Scatton, C. Le Douarin, 1984, Life sciences.

Regional pattern of increased ω 3 (peripheral type benzodiazepine) binding site densities in the rat brain induced by systemic injection of kainic acid

J. Bénavidès, B. Scatton, A. Dubois, 1991, Neuroscience Letters.

SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia

G. Griebel, J. Stemmelin, O. Bergis, 2007, Neuropsychopharmacology.

SSR126768A (4-Chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor

B. Scatton, J. Maffrand, E. Naline, 2004, Journal of Pharmacology and Experimental Therapeutics.

Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse.

B. Scatton, D. Duval, H. Poignet, 1991, European journal of pharmacology.

Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission.

B. Scatton, 1982, Life sciences.

Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat

J. Atkinson, B. Scatton, S. Z. Langer, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

Dopaminergic Neurons: Basic Aspects

B. Scatton, G. Bartholini, B. Zivkovic, 1989 .

Distribution of dopamine, noradrenaline and adrenaline in coronal sections of the rat lower brainstem

B. Scatton, B. Renaud, G. Chamba, 1985, Brain Research.

SL 81.0385: A novel selective and potent serotonin uptake inhibitor

H. Schoemaker, Y. Claustre, B. Scatton, 1988 .

Ornithine decarboxylase inhibition or NMDA receptor antagonism reduce cortical polyamine efflux associated with dialysis probe implantation

C. Carter, D. Fage, B. Scatton, 1993, Neuroscience Letters.

Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐d‐Aspartate Receptor Activation In Vivo

C. Carter, D. Fage, B. Scatton, 1992, Journal of neurochemistry.

Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.

G. Griebel, J. Simiand, P. Soubrié, 2002, The Journal of pharmacology and experimental therapeutics.

The GABA hypothesis of depression and antidepressant drug action.

B. Scatton, P. Morselli, K. Lloyd, 1985, Psychopharmacology bulletin.

L-glutamate increases internal free calcium levels in synaptoneurosomes from immature rat brain via quisqualate receptors

Y. Claustre, J. Bénavidès, B. Scatton, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

The NMDA receptor complex

B. Scatton, 1993, Fundamental & clinical pharmacology.

gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.

B. Scatton, G. Bartholini, 1982, The Journal of pharmacology and experimental therapeutics.

Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease

H. Schoemaker, B. Scatton, F. Javoy‐Agid, 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase.

B. Scatton, X. Vigé, D. Duval, 1994, European journal of pharmacology.

Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic

R. Depoortère, G. Perrault, G. Griebel, 2005, Neuropsychopharmacology.

Preclinical profile of befloxatone, a new reversible MAO-A inhibitor.

O. Bergis, O. Curet, B. Scatton, 1998, Journal of affective disorders.

Excitatory Amino Acid Influence on Striatal Cholinergic Transmission

D. Fage, B. Scatton, 1986 .

N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids

B. Scatton, J. Lehmann, 1982, Nature.

Characterization of the excitatory amino acid receptor-mediated release of [3H]acetylcholine from rat striatal slices

B. Scatton, J. Lehmann, 1982, Brain Research.

Gaba-Acetylcholine Interaction in the Rat Striatum

B. Scatton, G. Bartholini, 1981 .

Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics

J. Glowinski, B. Scatton, L. Julou, 1976, Brain Research.

Central serotonergic nerves project to the pial vessels of the brain

D. Duverger, B. Scatton, L. Edvinsson, 1983, Nature.

Distribution of monoaminergic, cholinergic, and GABAergic markers in the human cerebral cortex

Y. Agid, M. Ruberg, B. Scatton, 1989, Neuroscience.

Parkinson's disease and dementia

B. Scatton, F. Javoy‐Agid, F Javoy-Agid, 1987, Neurology.

The formation of deaminated metabolites of dopamine in the locus coeruleus depends upon noradrenergic neuronal activity

T. Dennis, O. Curet, B. Scatton, 1985, Brain Research.

Stressful environmental stimuli increase extracellular DOPAC levels in the prefrontal cortex of hypoemotional (Roman high-avoidance) but not hyperemotional (Roman low-avoidance) rats. An in vivo voltammetric study

B. Scatton, P. Driscoll, A. Serrano, 1988, Brain Research.

Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat.

C. Carter, B. Scatton, T. Dennis, 1987, The Journal of pharmacology and experimental therapeutics.

Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat.

Y. Claustre, B. Scatton, T. Dennis, 1986, The Journal of pharmacology and experimental therapeutics.

Potential Mechanisms Involved in the Negative Coupling Between Serotonin 5‐HT1A Receptors and Carbachol‐Stimulated Phosphoinositide Turnover in the Rat Hippocampus

Y. Claustre, J. Bénavidès, B. Scatton, 1991, Journal of neurochemistry.

Evidence for Differing Origins of the Serotonergic Innervation of Major Cerebral Arteries and Small Pial Vessels in the Rat

E. Mackenzie, G. Bonvento, D. Fage, 1991, Journal of neurochemistry.

Autoradiographic localization of muscarinic cholinergic receptors at various segmental levels of the human spinal cord

B. Scatton, F. Javoy‐Agid, A. Dubois, 1984, Neuroscience Letters.

Modulation of cholinergic transmission in the rat brain by GABA

B. Scatton, G. Bartholini, 1980, Brain Research Bulletin.

2-Oxo-[14C]glutarate is taken up by glutamatergic nerve terminals in the rat striatum

M. Savasta, C. Carter, D. Fage, 1986, Neuroscience Letters.

Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study

C. Carter, B. Scatton, R. L'heureux, 1988, Journal of neurochemistry.

The pharmacotherapy of focal cortical ischaemia in the mouse

E. Mackenzie, J. Bénavidès, B. Scatton, 1990, Brain Research.

Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe

B. Scatton, T. Nishikawa, 1983, Brain Research.

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

G. Griebel, J. Simiand, P. Soubrié, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Origin of dopaminergic innervation of the rat hippocampal formation

Herve Simon, H. Simon, B. Scatton, 1980, Neuroscience Letters.

The psychopharmacology of GABA synapses: update 1989.

B. Scatton, P. Morselli, K. Lloyd, 1990, Journal of neural transmission. Supplementum.

Indoleaminergic mechanisms in brain vessels; localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine.

D. Duverger, E. Mackenzie, B. Scatton, 1984, Acta physiologica Scandinavica.

Neurochemical studies on the existence, origin and characteristics of the serotonergic innervation of small pial vessels

D. Duverger, E. Mackenzie, D. Fage, 1985, Brain Research.

Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin.

B. Scatton, B Scatton, S. Langer, 1995, Molecular pharmacology.

Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphé nuclei

D. Duverger, E. Mackenzie, B. Scatton, 1988, Brain Research.

Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.

C. Carter, B. Scatton, K. Lloyd, 1990, The Journal of pharmacology and experimental therapeutics.

Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat

D. Fage, B. Scatton, A. Cudennec, 1997, Brain Research.

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.

P. Soubrié, M. Schumacher, Y. Claustre, 2002, The Journal of pharmacology and experimental therapeutics.

Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

D. Grandy, D. Sibley, J. Kebabian, 2019, IUPHAR/BPS Guide to Pharmacology CITE.

The gabaergic hypothesis of depression

B. Scatton, P. Morselli, K. Lloyd, 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Neurotransmitter interactions in the basal ganglia

C. Feuerstein, B. Scatton, M. Sandler, 1987 .

Mesocorticolimbic dopaminergic systems and emotional states

B. Scatton, A. Serrano, M. Bertolucci-D'Angio, 1990, Journal of Neuroscience Methods.

Antidepressant and potential antimanic actions of GABA receptor agonists

B. Scatton, P. Worms, K. Lloyd, 1983 .

Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia

G. Griebel, J. Stemmelin, D. Boulay, 2008, Pharmacology Biochemistry and Behavior.

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.

D J Sanger, R. Depoortère, G. Perrault, 1997, The Journal of pharmacology and experimental therapeutics.

Pharmacological and molecular targets in the search for novel antipsychotics

D. Sanger, B. Scatton, 2000, Behavioural pharmacology.

CNS Drug Reviews

G. Perrault, H. Schoemaker, G. Griebel, 2000 .

SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors

G. Perrault, H. Schoemaker, G. Griebel, 2001 .

Differential responsiveness of the rat dorsal and median raphe 5‐HT systems to 5‐HT1 receptor agonists and p‐chloroamphetamine

P. Blier, B. Scatton, A. Serrano, 1990, Synapse.

SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neurons

B. Scatton, N. Roome, D. Duval, 1992, Neuroscience Letters.

Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat brain

D. Duverger, B. Scatton, J. Nowicki, 1994, Brain Research.

Research report Effec(of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat brain

D. Duverger, B. Scatton, A. Cudennec, 1994 .

Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases.

B. Scatton, 1994, Life sciences.

N-Methyl-D-Aspartate Receptor Antagonists: A Novel Therapeutic Perspective for the Treatment of Ischemic Brain Injury

C. Carter, B. Scatton, C. Giroux, 1991 .

GABA mimetics decrease extracellular concentrations of 5-HIAA (as measured by in vivo voltammetry) in the dorsal raphe of the rat

B. Scatton, T. Nishikawa, A. Serrano, 1985, Brain Research.

GABA Theory of Depression and Antidepressant Drug Action

B. Scatton, K. Lloyd, G. Bartholini, 1989 .

GABA Receptors, Depression and Antidepressant Drug Action

B. Scatton, P. Morselli, K. Lloyd, 1987 .

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A): a potent and selective corticotrophin-releasing factor(1) receptor antagonist. I. Biochemical and pharmacological characterization.

G. Griebel, J. Simiand, P. Soubrié, 2002, The Journal of pharmacology and experimental therapeutics.

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

D. Duverger, E. Mackenzie, C. Carter, 1988, The Journal of pharmacology and experimental therapeutics.

Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.

B. Scatton, J. Allen, B. Peny, 1992, The Journal of pharmacology and experimental therapeutics.

Therapeutic potential of the atypical non-competitive NMDA receptor antagonists, ifenprodil and SL 82.0715, in ischaemic cerebrovascular diseases

E. Mackenzie, B. Scatton, B. Gotti, 1990 .

CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus

M. Maftouh, B. Scatton, G. Le Fur, 2007, The European journal of neuroscience.

Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography.

J. Baron, A. Patat, B. Scatton, 1996, European journal of pharmacology.

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390

M. Savasta, B. Scatton, Marc Savasta, 1986, Brain Research.

Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393.

B. Scatton, A. Dubois, 1985, European journal of pharmacology.

The potential use of GABA agonists in psychiatric disorders: Evidence from studies with progabide in animal models and clinical trials

B. Scatton, P. Worms, P. Morselli, 1983, Pharmacology Biochemistry and Behavior.

Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

Y. Claustre, L. Rouquier, B. Scatton, 2008, Neuroscience.

Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders

S. Stahl, G. Griebel, J. Stemmelin, 2008, Neuropsychopharmacology.

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

G. Griebel, J. Stemmelin, B. Scatton, 2005, Biological Psychiatry.

SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile

H. Schoemaker, P. Soubrié, Y. Claustre, 2003, Neuropsychopharmacology.

Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

S. Stahl, G. Griebel, J. Stemmelin, 2008, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

SL65.0155, A Novel 5-Hydroxytryptamine4 Receptor Partial Agonist with Potent Cognition-Enhancing Properties

P. Soubrié, O. Bergis, J. Bockaert, 2002, Journal of Pharmacology and Experimental Therapeutics.

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

Y. Claustre, D. Fage, B. Scatton, 1985, The Journal of pharmacology and experimental therapeutics.

In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.

G. Perrault, B. Scatton, A. Dubois, 1988, The Journal of pharmacology and experimental therapeutics.

Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat.

R. Dantzer, B. Scatton, M. Le Moal, 1982, Life sciences.

A radioenzymatic technique for the measurement of free and conjugated 3,4-dihydroxyphenylethyleneglycol in brain tissue and biological fluids

B. Scatton, T. Dennis, 1982, Journal of Neuroscience Methods.

Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.

J. Korf, B. Scatton, S. Bischoff, 1977, European journal of pharmacology.

SUBSENSITIVITY OF STRIATAL DOPAMINE TARGET CELLS AFTER REPEATED TREATMENT WITH APOMORPHINE DIPIVALOYL ESTER

M. Briley, B. Scatton, P. Worms, 1979 .

Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.

B. Scatton, P. Worms, 1977, European journal of pharmacology.

Pharmaceutical compositions containing nicotine and their application into tobacco weaning

B. Scatton, S. Jegham, P. George, 1999 .

The quantification of brain lesions with anω 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration

D. Duverger, E. Mackenzie, D. Fage, 1990, Brain Research.

Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat.

Y. Claustre, L. Rouquier, B. Scatton, 1988, The Journal of pharmacology and experimental therapeutics.

Determination of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in rat and human brain and biological fluids by reversed-phase high-performance liquid chromatography with electrochemical detection.

B. Scatton, L. Bossi, L. Semerdjian-Rouquier, 1981, Journal of chromatography.

Cerebral circulatory and metabolic effects of perivascular neurotransmitters.

E. Mackenzie, B. Scatton, 1987, CRC critical reviews in clinical neurobiology.

Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors

M. Savasta, O. Curet, B. Scatton, 1986, Neuroscience.

Quantitative motor assessment in FALS mice: a longitudinal study

D. Sanger, B. Scatton, P. Barnéoud, 1997, Neuroreport.

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain

Gilles Bonvento, G. Bonvento, Y. Claustre, 1992, Neuroscience Letters.

Lesions of the posterior septum or of the habenula decrease [3H]hemicholinium-3 binding (as measured by autoradiography) in the interpeduncular nucleus of the rat

B. Scatton, N. Motohashi, A. Dubois, 1987, Neuroscience Letters.

Functional mapping of the effects of lesions of the habenular nuclei and their afferents in the rat

E. Mackenzie, B. Scatton, N. Motohashi, 1986, Brain Research.

Inhibitory influence of GABA on central serotonergic transmission. Involvement of the habenulo-raphe´pathways in the GABAergic inhibition of ascending cerebral serotonergic neurons

B. Scatton, T. Nishikawa, 1985, Brain Research.

Inhibitory GABAergic influence on striatal serotonergic transmission exerted in the dorsal raphe as revealed by in vivo voltammetry

B. Scatton, T. Nishikawa, A. Serrano, 1984, Brain Research.

The inhibitory GABAergic influence on striatal serotonergic neurons depends upon the habenulo-raphe pathways

B. Scatton, T. Nishikawa, 1984, Brain Research.

Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum

M. Savasta, C. Feuerstein, B. Scatton, 1987, Neuroscience Letters.

Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat

D. Fage, B. Scatton, T. Nishikawa, 1986, Brain Research.

Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.

B. Scatton, 1982, The Journal of pharmacology and experimental therapeutics.

Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission

M. Savasta, B. Scatton, A. Dubois, 1988, Neuroscience Letters.

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

R. Depoortère, G. Perrault, G. Griebel, 2005, Psychopharmacology.

Differential Effects of Forced Locomotion, Tail‐Pinch, Immobilization, and Methyl‐β‐Carboline Carboxylate on Extracellular 3,4‐Dihydroxyphenylacetic Acid Levels in the Rat Striatum, Nucleus Accumbens, and Prefrontal Cortex: An In Vivo Voltammetric Study

B. Scatton, M Bertolucci-D'Angio, A Serrano, 1990, Journal of neurochemistry.

NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens.

B. Scatton, A Serrano, B Scatton, 1989, European journal of pharmacology.

Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission.

Y. Claustre, L. Rouquier, B. Scatton, 1991, European journal of pharmacology.

5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus.

Y. Claustre, B. Scatton, J. Benavides, 1988, European journal of pharmacology.

Biochemical evidence for a transmitter role of dopamine in the rat hippocamus

J. Korf, B. Scatton, S. Bischoff, 1979, Brain Research.

Lack of involvement of alpha 2-adrenoceptors in the regulation of striatal dopaminergic transmission.

B. Scatton, J. Dědek, B. Ẑivković, 1983, European journal of pharmacology.

Drug-induced changes of epinephrine turnover in the rat hypothalamus.

B. Scatton, G. Bartholini, 1981, Life sciences.

Serotonergic Neuron Stimulation Modulates Thalamocortical Glucose Use in the Conscious Rat

D. Duverger, E. Mackenzie, B. Scatton, 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.

P. Baud, B. Scatton, S. Z. Langer, 1985, The Journal of pharmacology and experimental therapeutics.

Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine

B. Scatton, F. Javoy‐Agid, Bernard Scatton, 1986, Brain Research.

Inhibitory influence of GABA on central serotonergic transmission. Raphe´nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons

B. Scatton, T. Nishikawa, 1985, Brain Research.

Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor.

C. Carter, B. Scatton, J. Rivy, 1989, European journal of pharmacology.

Cortical modulation of striatal function

B. Scatton, P. Worms, K. Lloyd, 1982, Brain Research.

Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester

B. Scatton, P. Worms, 1979, The Journal of pharmacy and pharmacology.

Increase in striatal acetylcholine levels by GABA mimetic drugs: lack of involvement of the nigro-striatal dopaminergic neurons.

B. Scatton, G. Bartholini, 1979, European journal of pharmacology.

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related

G. Griebel, J. Simiand, P. Soubrié, 2002, The Journal of pharmacology and experimental therapeutics.

3-thiazol-2-amine Hydrochloride ( SSR 125543 A ) , a Potent and Selective Corticotrophin-Releasing Factor 1 Receptor Antagonist . II . Characterization in Rodent Models of Stress-Related Disorders

G. Griebel, J. Simiand, P. Soubrié, 2002 .

Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.

B. Scatton, F. Lhoste, J. Lorrain, 1985, Journal of Pharmacology and Experimental Therapeutics.

Noradrenaline Antagonizes and Ouabain Potentiates the Effects of iV‐Methyl‐D‐Aspartate on Rat Cerebellar Cyclic GMP Production

C. Carter, B. Scatton, J. Gueugnon, 1988, Journal of neurochemistry.

Sodium dependence of NMDA's effects on cyclic GMP production in immature rat cerebellar slices

C. Carter, B. Scatton, F. Noel, 1988, Neuroscience Letters.

Differential modulation of [3H]TCP binding to the NMDA receptor by L-glutamate and glycine.

C. Carter, B. Scatton, J. Rivy, 1988, European journal of pharmacology.

Antagonism by N g-nitro-l-arginine ofl-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy

B. Scatton, X. Vigé, J. Nowicki, 1993, Neuroscience.

DOPAMINE RECEPTORS MODULATING THE RELEASE OF SEVERAL NEUROTRANSMITTERS IN THE PERIPHERAL AND CENTRAL NERVOUS SYSTEM

P. Baud, B. Scatton, S. Z. Langer, 1984 .

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

E. Hirsch, Y. Agid, M. Ruberg, 1985, Annals of neurology.

Biochemical and histological alterations induced by fluid percussion brain injury in the rat

B. Scatton, B. Scatton, S. Toulmond, 1993, Brain Research.

Definitive disruption of spatial delayed alternation in rats after lesions in the ventral mesencephalic tegmentum

H. Simon, B. Scatton, M. Lemoal, 1979, Neuroscience Letters.

Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.

Y. Claustre, B. Scatton, S. Z. Langer, 1988, Life sciences.

Quantitative autoradiography of 3H-nomifensine binding sites in rat brain.

M. Dubocovich, D. Fage, B. Scatton, 1985, Life sciences.

Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain.

B. Scatton, 1980, Advances in biochemical psychopharmacology.

Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3 H]N-n-propylnorapomorphine binding sites

B. Scatton, A. Dubois, 1985, Neuroscience Letters.

Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobalt-induced epilepsy in the rat

S. Trottier, P. Chauvel, J. Caboche, 1983, Brain Research.

SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic Activity

R. Depoortère, G. Perrault, J. Simiand, 2003, Neuropsychopharmacology.

Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.

A. Roach, B. Scatton, R. Gomeni, 1982, The Journal of pharmacology and experimental therapeutics.

LACK OF EVIDENCE FOR AXONAL TRANSPORT OF D1 AND D2 RECEPTORS IN THE NIGRO‐STRIATAL PATHWAY OF THE RAT

M. Savasta, B. Scatton, A. Dubois, 1988, Fundamental & clinical pharmacology.

Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat

M. Savasta, B. Scatton, A. Dubois, 1986, Neuroscience Letters.

Influence of GABA mimetics and lithium on biochemical manifestations of striatal dopamine target cell hypersensitivity.

D. Fage, A. Oblin, B. Scatton, 1985, Psychopharmacology. Supplementum.

SL25.1131 [3(S),3a(S)-3-Methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a New, Reversible, and Mixed Inhibitor of Monoamine Oxidase-A and Monoamine Oxidase-B: Biochemical and Behavioral Profile

C. Carter, O. Curet, B. Scatton, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization

D. Duverger, E. Mackenzie, J. Mcculloch, 1987, Brain Research.

Neuroprotective Effects of Eliprodil in a Rat Hippocampal Slice Hypoxia Model

B. Scatton, R. Santamaria, D. Françon, 1997, Annals of the New York Academy of Sciences.

Dopamine receptors in GtoPdb v.2023.1

D. Grandy, D. Sibley, J. Kebabian, 2023, IUPHAR/BPS Guide to Pharmacology CITE.

Lesion of nucleus basalis magnocellularis decreases [3H]hemicholinium-3 binding (as measured by autoradiography) in the amygdala and frontal cortex of the rat

B. Scatton, A. Dubois, Nobutake Motohashi, 1986, Neuroscience Letters.

Imaging of human brain lesions with an omega 3 site radioligand.

E. Mackenzie, P. Cornu, B. Scatton, 1988, Annals of neurology.

Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat

D. Duverger, E. Mackenzie, D. Fage, 1988, Brain Research.

Acute and subacute effects of haloperidol on dopac levels in the substantia nigra and ventral tegmental area of rat brain.

B. Scatton, 1979, European journal of pharmacology.

Raised extracellular potassium relieves the blockade by magnesium of NMDA-induced cerebellar cyclic GMP production

C. Carter, B. Scatton, F. Noel, 1987, Neuroscience Letters.

Effect of single and repeated administration of haloperidol and sulpiride on striatal and retinal dopamine turnover in the rat

J. Korf, B. Scatton, J. Dědek, 1977, Brain Research.

Dihydropyridine- and omega-conotoxin-resistant, neomycin-sensitive calcium channels mediate the depolarization-induced increase in internal calcium levels in cortical slices from immature rat brain.

B. Scatton, M. Perrier, J. Benavides, 1992, The Journal of pharmacology and experimental therapeutics.

An in Vivo Voltammetric Study of the Response of Mesocortical and Mesoaccumbens Dopaminergic Neurons to Environmental Stimuli in Strains of Rats with Differing Levels of Emotionality

B. Scatton, P. Driscoll, A. Serrano, 1988, Annals of the New York Academy of Sciences.

Tail-pinch stress increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the rat nucleus accumbens but not frontal cortex: antagonism by diazepam and zolpidem

B. Scatton, A. Serrano, J. Rivy, 1987, Brain Research.

Involvement of mesocorticolimbic dopaminergic systems in emotional states.

B. Scatton, M Bertolucci-D'Angio, A Serrano, 1990, Progress in brain research.

Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat

C. Feuerstein, D. Fage, B. Scatton, 1987, Brain Research.

Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission

O. Curet, B. Scatton, T. Nishikawa, 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

GABA mimetics increase extracellular DOPAC (as measured by in vivo voltammetry) in the rat locus coeruleus

B. Scatton, A. Serrano, 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

Omega 3 (peripheral type benzodiazepine binding) site distribution in the rat immune system: an autoradiographic study with the photoaffinity ligand [3H]PK 14105.

E. Hamel, B. Scatton, A. Dubois, 1989, The Journal of pharmacology and experimental therapeutics.

Langer et al. reply

H. Schoemaker, B. Scatton, W. Rein, 1998 .

Pergolide versus bromocriptine

Y. Agid, B. Scatton, France Jauoy-Agid, 1984, Neurology.

Proposal for an ‘omega modulatory site’ nomenclature to replace the benzodiazepine receptor denomination

B. Scatton, S. Z. Langer, S. Arbilla, 1991, European Neuropsychopharmacology.

Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle.

H. Lôo, B. Scatton, G. Le Fur, 1985, Neuropsychobiology.

Feeding or exposure to food odors increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the prefrontal cortex of food-deprived rats

B. Scatton, Magali D'Angio, Bernard Scatton, 1989, Neuroscience Letters.

Recent findings in central dopaminergic and cholinergic neurotransmission of roman high- and low-avoidance (RHA/Verh and RLA/Verh) rats

Y. Claustre, D. Fage, B. Scatton, 1987, Behavioural Brain Research.

Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems

J. Glowinski, A. Thierry, B. Scatton, 1975, Brain Research.

PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report.

C Crouzel, S. Pappatà, Y. Samson, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Modulation by GABA of cholinergic transmission in the striatum

B. Scatton, G. Bartholini, 1980, Brain Research.

Amisulpride: from animal pharmacology to therapeutic action

G. Perrault, D. Sanger, H. Schoemaker, 1997, International clinical psychopharmacology.

The imidazopyridine derivatives zolpidem and alpidem discriminate between central ω (benzodiazepine) receptor subtypes in rat brain sections

B. Scatton, B. Peny, J. Benavides, 1991, European Neuropsychopharmacology.

SL 85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist properties

H. Schoemaker, Y. Claustre, B. Scatton, 1990 .

Imaging of human brain lesions with an ω3 site radioligand

Philippe Cornu, T. Dennis, E. Mackenzie, 1988 .

An Obituary to Jacques Glowinski (1936-2020).

J. Girault, M. Hamon, B. Scatton, 2021, Journal of neurochemistry.

Pharmacological characterisation and autoradiographic distribution of polyamine-sensitive [3H]ifenprodil binding sites in the rat brain

H. Schoemaker, B. Scatton, C. Dana, 1991, Neuroscience Letters.

Decrease in both choline acetyltransferase activity and EEG patterns in the hippocampal formation of the rat following septal macroelectrode implantation

J. Delacour, D. Fage, B. Scatton, 1984, Brain Research.

Interaction of GABA mimetics with nigro-striatal dopamine neurons

B. Scatton, P. Worms, K. Lloyd, 1979, Brain Research Bulletin.

DOPAMINE NEURON ACTIVITY: EFFECT OF SL 76 002, A NEW GABA MIMETIC CANDIDATE

B. Scatton, P. Worms, K. Lloyd, 1979 .

Increase in dopamine and DOPAC levels in noradrenergic terminals after electrical stimulation of the ascending noradrenergic pathways

T. Dennis, O. Curet, B. Scatton, 1984, Brain Research.

Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. I. Effects of electrolytic or neurotoxic lesions of the dorsal and/or median raphé nucleus

D. Duverger, E. Mackenzie, B. Scatton, 1988, Brain Research.

Peripheral Type Benzodiazepine Binding Sites as a Tool for the Detection and Quantification of CNS Injury

B. Scatton, A. Dubois, J. Benavides, 1999, Current protocols in neuroscience.

Critical review on quantitative autoradiography of D1 and D2 dopaminergic receptors in the striatum of the mammalian brain: differential localization and plastic changes after pharmacological manipulation and dopaminergic input disruption.

J. Thibault, M. Geffard, N. Mons, 1989, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.

B. Scatton, G. Bartholini, B. Ẑivković, 1980, Advances in biochemical psychopharmacology.

Temporal effects of habenular lesions on glucose utilization in the anterior raphé nuclei of the rat

E. Mackenzie, B. Scatton, N. Motohashi, 1986, Neuroscience Letters.

Zolpidem functionally discriminates subtypes of native GABAA receptors in acutely dissociated rat striatal and cerebellar neurons

B. Scatton, P. Avenet, H. Depoortere, 1996, Neuropharmacology.

Differential influence of GABA-ergic agents on dopamine metabolism in extrapyramidal and limbic systems of the rat

B. Scatton, G. Bartholini, B. Ẑivković, 1980, Brain Research Bulletin.

Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression

C. Benkelfat, H. Lôo, B. Scatton, 2004, Psychopharmacology.

Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.

J. Glowinski, B. Scatton, L. Julou, 1977, Advances in biochemical psychopharmacology.

[3H]imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotonergic neurons.

Y. Agid, M. Ruberg, B. Scatton, 1983, European journal of pharmacology.

Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers

G. Perrault, D. Sanger, H. Schoemaker, 1997 .

Evidence for the involvement of presynaptic alpha-2 adrenoceptors in the regulation of norepinephrine metabolism in the rat brain.

O. Curet, B. Scatton, T. Dennis, 1987, The Journal of pharmacology and experimental therapeutics.

Monoamine abnormalities in the brain of scrapie-infected rats

D. Fage, B. Scatton, M. Bassant, 1984, Brain Research.

Differential Effects of Electrical Stimulation of the Dorsal Raphe Nucleus and of Cervical Sympathectomy on Serotonin and Noradrenaline Concentrations in Major Cerebral Arteries and Pial Vessels in the Rat

E. Mackenzie, G. Bonvento, L. Rouquier, 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.

Y. Claustre, B. Scatton, B. Eudeline, 1992, European journal of pharmacology.

Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine

B. Scatton, F. Javoy‐Agid, A. Dubois, 1986, Brain Research.

Peripheral Type Benzodiazepine Binding Sites as a Tool for the Detection and Quantification of CNS Injury

B. Scatton, A. Dubois, J. Benavides, 1999, Current protocols in neuroscience.

SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

G. Perrault, H. Schoemaker, G. Griebel, 2001, Journal of Pharmacology and Experimental Therapeutics.

Effect of single and repeated administration of haloperidol and sulpiride on striatal and retinal dopamine turnover in the rat

J. Korf, B. Scatton, J. Dědek, 1977, Brain Research.

Autoreceptor-mediated Control of Serotonin Release in the Rat Brain in vivo

G. Bonvento, P. Blier, L. Rouquier, 1991 .

The role of cytokines in neural pathology

B. Scatton, F. Bourdiol, J. Benavides, 1991, European Neuropsychopharmacology.

Protracted treatment with diazepam reduces benzodiazepine1 receptor-mediated potentiation of gamma-aminobutyric acid-induced currents in dissociated rat hippocampal neurons.

G. Perrault, B. Scatton, P. Granger, 1996, The Journal of pharmacology and experimental therapeutics.